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ABSTRACT  High  speed  centrifugal fractionation  of homogenates of rabbit 
skeletal muscle has led to the discovery of a soluble muscle-relaxing factor in 
the  homogenate.  Assay  of  the  relaxing  activity  with  deoxycholate-treated 
myofibrils  and  reconstituted  actomyosin  systems  has  established  that  the 
activity is  not produced by the presence of contaminants.  Relaxing activity 
could be removed or destroyed by charcoal, dialysis,  prolonged heating, and 
treatment with the chelating resin, chelex-100,  making it improbable that the 
effect is due simply to calcium deficiency. Many of the characteristics of this 
muscle-relaxing factor suggest that it is very similar to or the same as the factor 
formed by the incubation of muscle granule fractions and ATP. Evidence is pre- 
sented that some soluble protein component is involved in the stabilization of 
the factor. The relaxing activity could be separated from the high molecular 
weight material in the supernatant by the technique of gel filtration. On the 
basis  of the gel used, the molecular weight of the active agent should be less 
than 4000. 
INTRODUCTION 
A  preliminary communication by Fuchs and Briggs  (1)  noting that muscle 
possesses  a  soluble  material  capable  of  inhibiting  ATPl-induced  tension 
generation  in  glycerinated muscle fibers  has  added  considerable  weight  to 
the supposition that the Marsh muscle-relaxing system (2),  by the formation 
of such  an  inhibitor  (3),  is  responsible  for relaxing  contracted muscle and 
keeping it in  the resting state.  Acceptance of this  hypothesis requires,  how- 
ever, demonstration that the relaxing activity attributed to this soluble factor, 
isolated directly from muscle, is not due to contamination of the assay systems 
or the soluble system by the particulate portion of Marsh extract; for studies 
by Hasselbach (4) have indicated the persistence of remnants of endoplasmic 
reticulum  in  glycerinated muscle  fibers  and  myofibrils,  materials  used  for 
the assay of soluble relaxing factor in previous studies (1, 3, 5, 6). Uncontami- 
i Abbreviations: ATP, adenosinetriphosphate; EDTA, ethylenediaminetetraacetate. 
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nated  assay systems were,  therefore,  developed in  the  preceding  paper  (7) 
so  that it would be possible  to determine whether the activity found in the 
soluble  portion  of the  muscle  homogenate is  authentic.  Acceptance  of the 
soluble inhibitor hypothesis also requires  that the relaxing effects produced 
by preparations purported  to contain such a  factor are  actually due to the 
presence  of some substance therein rather than the abscence of calcium as sug- 
gested by Ebashi (8)  and A. Weber (9,  10).  By directed study of the physico- 
chemical  properties of the soluble relaxing  factor  a  decision between these 
two possibilities has been  achieved. 
MATERIALS  AND  METHODS 
The  compositions of extraction solution and  contraction solution,  as  well  as  the 
method of preparation of crude Marsh extract, granule fraction, supernatant frac- 
tion, glycerinated muscle fibers, and myofibrils, are presented in the preceding com- 
munication (7). 
Limitations on the possible molecular size of soluble relaxing factor were achieved 
by the technique of gel filtration described by Porath and Flodin (11). The gels used 
in  these  studies,  sephadex  G-50  and  G-25  (obtained  from Pharmacia,  Box  100, 
Rochester, Minnesota), were washed with 2 mM EDTA  to remove contaminating 
metals.  They were  then  equilibrated  with  contraction  solution  and  packed  into 
20  X 200 mm columns. Void volumes were determined with hemoglobin. The volume 
of the supernatant fraction placed on the column was equal to two-thirds the void 
volume. The columns were eluted with contraction solution and 5 ml fractions were 
collected for analysis of protein and relaxing activity. All procedures were carried 
out in a cold room at 9-5 o. 
Chelex-100,  200 to 400 mesh, was purchased from the California Corporation for 
Biochemical Research, Los Angeles, California. Chelex-I00 is prepared by chemically 
attaching iminodiacetate exchange groups to a  styrene-divinylbenzene lattice. This 
gives  a  resin with complexing properties  similar to  those displayed by EDTA  in 
solution; i.e.,  a high affinity for divalent cations.  Before use, an aqueous suspension of 
the resin was neutralized to pH 7 with HCI, and then mixed with a 5 rnM solution of 
EDTA to remove contaminating divalent metals. The mixture was filtered and the 
resin washed exhaustively with double glass-distilled  water. 
Purified actin and myosin were prepared  according to the procedures given by 
Mommaerts (12). G-actin was converted to F-actin with KCI (100 rr~) and MgCI~ 
(1  rnu).  Reconstituted actomyosin was  obtained  by mixing 4  parts  by weight of 
myosin, dissolved in 0.6 u  KC1 with I part F-actin. The mixture was diluted with 10 
volumes of distilled water and the precipitate resuspended in extraction solution. 
Syneresis  of synthetic actomyosin and myofibrils was measured by a  procedure 
similar to that of Mueller (13). A predetermined amount of protein was pipetted into 
graduated Kolmer type centrifuge tubes containing contraction solution or super- 
natant solutions  containing 5 mM ATP which had been allowed to come to room 
temperature  (22-24°C).  The  tubes  were  mixed  by  inverting  them  several  times F.  Fucz~s AND F. N.  BaIoos  Properties  o/a Soluble Relaxing Factor  895 
during a period of about 30 seconds and the volume of precipitate was measured after 
centrifugation for 3 minutes at 1500 RPM in a refrigerated centrifuge. 
The activated charcoal (norit A) used in the adsorption experiments was treated 
with  10 mM EDTA, then with 0.01 M HC1, thoroughly washed with double glass- 
distilled water, and dried. 
Dialysis was carried out with ordinary cellophane dialysis tubing which had been 
washed with a  solution of 5 mM EDTA and then rinsed with double glass-distilled 
water. 
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syneresis  of  uncontaminated 
actomyosin  preparations. Myofibril  and actomyosin  syneresis  were measured as described 
in text. (a) Reconstituted actomyosin, 11.2 mg in a final  volume of 8 ml. (b) Myofibrils 
treated with deoxycholate as described in (7). MyofibriUar protein, 30 mg in a final 
volume of 8 ml: Ppte, volume of myofibril  or actomyosin  precipitate (syneresis  volume). 
Volume per cent indicates the percentage of the volume of the solution occupied by 
supernatant. The reversibility  of inhibition was tested by adding calcium (16 #moles). 
RESULTS 
A.  Demonstration  of the Relaxing  Activity  of Supernatant  Fraction 
Proof that the relazing activity of the supernatant fraction from muscle does 
not depend  upon  any contaminant in  the  assay system has  been  achieved 
through  the  use  of  two  types  of  actomyosin  preparations:  reconstituted 
actomyosin,  established  to  be  free  of  endoplasmic  reticular  material  by 
electron microscopy (4), and deoxycholate-treated myofibrils (7). The results 
are presented in Fig.  1. As indicated in this figure, dilution of the supernatant 
fraction as much as four to five times with contraction solution reduced only 
slightly the capacity to inhibit syneresis. Dilution beyond that point, however, 
quickly led to complete loss of relaxing activity. The reversibility of the effect 
of supernatant was demonstrated by adding  16  umoles of CaCI~ to 8  ml of 
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To  establish  that  the  component of the  supernatant  fraction responsible 
for its  relaxing  activity is  truly a  soluble,  i.e.  non-particulate material,  the 
relaxing  activity  of the  supernatant  fraction  was  separated  from  all  large 
molecular weight  components  of the  supernatant  by  the  technique  of gel 
filtration  (11).  Columns  of sephadex  G-50  and  G-25  were  used  for  this 
purpose.  The structure of the gel,  G-50,  is such that it excludes material of 
molecular weight greater than  10,000  from the water phase within  the gel. 
As  shown in  Fig.  2,  when supernatant  was  subjected  to  such  a  procedure, 
none  of the  relaxing  activity was  associated  with  the  protein material nor 
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FIGu~ 2.  Separation of soluble relaxing factor by gel filtration. Relaxing activity was 
assayed by inhibition of tension generation in single glycerinated muscle fibers. Five ml 
fractions were collected from a sephadex, G-50 column and numbered sequentially as 
indicated on the abscissa. Other details of the experiment are given in the text. 
did it appear within the void volume of the column, indicating that it had 
equilibrated  with  the  internal  water  of the  gel  and  hence,  is  of molecular 
weight  less  than  10,000.  Experiments  with  sephadex  G-25  yielded  similar 
results;  i.e.,  the relaxing activity appeared  after the void volume had  been 
eluted,  hence, the molecular weight can be  set as  less  than 4,000.  Unfortu- 
nately, the relaxing activity so isolated was highly unstable and could be kept 
at 0 ° for no longer than 24 hours. This was in contrast to the relaxing activity 
in  the  unfractionated  supernatant  which  could  be  stored  at  0 °  for  4  to  6 
days.  These  observations  suggest  that  the  protein  portion  of supernatant 
stabilizes  the soluble relaxing factor,  a  conclusion reached earlier by Fuchs 
and Briggs (1). 
Further evidence that no particulate substance is involved in the relaxing F.  FUCHS AND F.  N.  Bmcos  Properties  of a 8oluble Relaxing Factor  897 
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activity of the supernatant fraction was  provided by  experiments in which 
the sensitivities of crude Marsh  extract,  granules,  and  supernatant fraction 
to sonic vibration were investigated. Gergely et al.  (14)  have shown that the 
granule fraction is sensitive to sonic vibration; presumably the crude Marsh 
extract and supernatant fraction would also be sensitive to sonic vibration if 
they depended upon any particulates therein for their relaxing activity. The 
effect of 20 minutes of  sonic vibration at 9 kc is illustrated in Fig. 3. As noted by 
Gergely et al. the granule fraction was completely inactivated. In contrast, the 
supernatant fraction was completely insensitive to sonic vibration. The crude 
Marsh extract was partially inactivated. These results are not unexpected if it 
is  assumed that  the relaxing activity of the crude Marsh  extract is derived 
from the presence of both a  soluble relaxing factor and a particulate relaxing 
factor. 
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B.  Physicochemical Properties of the Supernatant Fraction in Relation 
to Relaxing Activity 
I.  THERMAL  STABILITY 
The relaxing activity of a  supcrnatant preparation after heating at  100 ° for 
various intervals  of time is  reported  in  Fig.  4.  Before the  supernatant  was 
assayed,  coagulated  protein  was  removed  by  centrifugation.  Quite  clearly 
there was a  steady loss of activity as the interval of heating was lengthened. 
The  stability  of  the  hcat-deproteinizcd  supernatant  fraction  was  also 
investigated. Fig. 5 compares the relaxing activity remaining in a heat-depro- 
tcinizcd  preparation  and  a  control  preparation  after  l,  2,  and  3  days  of 
storage at  2 °.  The relaxing activity of the heat-denatured supernatant was 
much more labile than that of the non-treated preparation, very little activity 
remaining at  the end of 3  days.  The control preparation lost about 60  per 
cent of its activity in 3 days'  time. 
2.  REMOVAL  OF  SUPERNATANT  RELAXING  ACTIVITy  BY  ADSORPTION 
The inactivation of supcrnatant by the addition of 30 mg of charcoal per ml 
of supernatant  is  shown in  Fig.  6  a.  The  supernatant  was  exposed  to  the F.  I?UCHS AND  F.  N.  BRIOOS  Properties  of a Soluble  Relaxing  Factor  899 
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Fxoum~ 5.  Effect of heating on stability of supernatant.  Supernatant was heated at 
100 ° for 3 minutes. Denatured protein was removed by centrifugation. Relaxing activity 
was assayed with glycerinated psoas fibers. The numbers on the curves represent the 
age (in days) of the preparation after the heat treatment. 
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FmURE 6.  Adsorption of supernatant relaxing activity. Myofibril syneresis  was meas- 
ured  as described in text.  (a)  Supernatant  treated  with charcoal as described in text. 
Myofibrillar  protein,  30  mg in  final  volume  of 8  ml.  (b)  Supernatant  treated  with 
chelex-100 as described in text.  Myofibrillar protein,  30 mg in final volume of 8  ml. 
PPTE, myofibril precipitate volume (syneresis volume). 
charcoal  for  10  minutes  at  0 °.  Then  the  charcoal  was  removed  from  the 
supernatant by 1 hour of centrifugation at 78,000 g. Inasmuch as the charcoal 
was treated with both acid and EDTA, the likelihood of calcium contamina- 
tion is  quite remote.  Therefore, it seems likely that the loss of activity was 
due to charcoal adsorption of the ingredient responsible for producing relaxa- 
tion.  The  possible  adsorption  of relaxing  activity by  chelex-100  was  also 
investigated because  its  ability to  complex  calcium makes  it  unlikely that 900  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  46  "  I963 
any loss of relaxing  activity attendant  upon its use could possibly occur as a 
consequence  of  surreptitious  addition  of  calcium.  Before  the  chelex-100- 
treated  supernatant  was assayed,  sufficient magnesium was added  to replace 
that  removed by the resin.  As indicated  in Fig.  6  b,  there was a  total loss of 
relaxing activity as a  consequence of exposure of supernatant  to this resin. 
3.  DIALYSIS 
Evidence  that  the  relaxing  activity  of  soluble  preparations  is  not  due  to 
calcium deficiency,  but to  the presence of some agent,  is obtained  from the 
pair of dialysis experiments shown in Fig.  7.  In the first of this pair of experi- 
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A, Active supernatant  outside sac. 
rq, Dialyzed supernatant  inside sac. 
e, Dialyzed supernatant  inside sac +  2 
n~ CaCI~. 
X, Extraction solution inside sac. 
C), Dialyzed supernatant. 
Fmo~ 7.  The dialyzability of the relaxing factor activity of supernatant.  Myofibrillar 
syneresis was measured as described in  text.  Dialyzed supernatant  was prepared  by 
dialyzing 1 volume of active supernatant  for 40 hours at 2-4°C against 40 volumes of 
chelex-treated extraction solution. For second dialysis, I volume each of dialyzed super- 
natant and extraction solution was dialyzed for 18 hours at 2--4°C against  10 volumes 
of active supernatant.  Myofibrillar protein,  30 mg in final volume of 8 nil. 
ments,  I0 volumes of Marsh  supernatant  were dialyzed for  18 hours  against 
1 volume of extraction solution.  At the end of the dialysis period,  the Marsh 
supernatant  possesses relaxing  activity.  The  extraction  solution  possessed no 
relaxing  activity. The second part of the experiment consisted of dialyzing  a 
similar  10 volumes of Marsh supernatant  against  1 volume of dialyzed super- 
natant.  This experimental procedure was suggested by studies  (I) which had 
indicated  that  soluble  muscle  protein  somehow  stabilizes  relaxing  activity. 
It was felt that the inability to demonstrate relaxing activity in the extraction 
solution might  be due to rapid  loss of activity in a  non-protein  environment. 
In order to provide such an environment,  a fraction of the Marsh supernatant 
was  inactivated  by dialysis  (dialyzed  supernatant).  As  indicated  in  Fig.  7, F.  FUaHS AND  F.  1~.  BRiaas  Properties  of a Soluble Relaxing Factor  9oi 
when active Marsh supernatant was dialyzed against the inactive supernatant, 
relaxing activity was transferred to the inactive supernatant.  If Marsh super- 
natant depended upon a calcium deficiency for its relaxing activity, then that 
deficiency should  have  equilibrated  with  extraction  solution  as  readily as 
with dialyzed supernatant. 
DISCUSSION 
Though it originally appeared that the muscle-relaxing activity of the muscle 
homogenates described by Marsh is  attributable  to the microsomal fraction 
thereof (15,  16),  it now seems justifiable to conclude that a  soluble relaxing 
factor  also  exists  in  such  homogenates.  In  support  of  this,  the  soluble 
relaxing  activity of the  homogenate has  been  shown  to  be  fully active  on 
reconstituted as well as deoxycholate-treated actomysin systems. The relaxing 
activity of the supernatant is thus totally independent of any intrinsic relaxing 
agents in the assay system. 
FIGURE 8.  Schematic  representation of the var- 
ious  hypotheses  proposed  to  explain how  gran- 
ules (G) inhibit actomyosin. 
~'  C7),~  EDrA 
Fig.  8  indicates schematically the various  mechanisms which have  been 
proposed for the granule inhibition of actomyosin systems; i.e., "relaxation." 
The central role of calcium in this scheme is based on the ease with which 
calcium reverses all relaxation  systems. Reaction  3  is well substantiated  by 
the  works  of  Ebashi  (8),  Parker  and  Gergely  (5),  and  Hasselbach  (17). 
However,  since  the  uptake  of calcium is  an  active  process,  it  is  doubtful 
whether an equilibrium constant can justifiably be  applied  to this  reaction 
(8).  If the relaxation produced by granules is due merely to the withdrawal 
of calcium, then the level of calcium which determines actomyosin activity 
must be measured (reaction 1) and the levels so established must be achieved 
by the granules (reaction 3).  Ebashi  (8)  and A. Weber (9,  10),  through the 
use  of EDTA  and  other calcium-chelating agents,  have studied reaction  2 
and have shown that actomyosin systems relax at predictable values--though 
they do not agree on a  particular value of ionized calcium--and conclude, 
therefore,  that  reaction  1  is  of prime  importance.  On  the  other  hand,  a 
comparative study of the influence of a  particulate chelator, chelex-100, and 
granules on calcium levels and actomyosin activity by Briggs and King (18) 
does not support the predictability of calcium levels and actomyosin activity. 
An important  defect in  the hypothesis of Weber and  Ebashi  is  the lack of 902  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  4 6  •  x963 
evidence that reaction 3 can lead to the levels of calcium required by analy- 
sis of reaction 2. 
The alternative mechanism for the relaxation of actomyosin, i.e. the forma- 
tion of a  soluble inhibitor R,  reaction 4,  is favored by the results presented 
in this communication. The evidence to be considered first excludes reaction 
3 as the basis for relaxing activity. The possibility that the relaxing activity 
of the supernatant is due to calcium deficiency rather than to the postulated 
inhibitor  R  has  been  considered.  However,  the  physicochemical  charac- 
teristics of the supernatant relaxing factor completely exclude this explanation 
of its  relaxing  activity.  Heating  destroyed  relaxing  activity  but  could  not 
reverse  a  calcium  deficiency.  Charcoal  and  chelex-100  adsorbed  relaxing 
activity but could not adsorb a calcium deficiency. It is also impossible, within 
the framework of the calcium deficiency hypothesis, to explain the dialysis 
experiments. Thus, when equal volumes of inactive supernatant and extrac- 
tion  solution were  dialyzed  against  a  large  volume of active  supernatant, 
relaxing  activity reappeared  in  the inactive  supernatant,  but  never in  the 
extraction solution. Whatever the calcium concentration in the supernatant, 
it should have equilibrated equally with the inactive supernatant and extrac- 
tion solution.  The  restoration  of activity  only to  the dialyzed  supernatant 
must, therefore, be ascribed to the inward movement of the small but labile 
inhibitor designated R  in this scheme. 
The  mechanism  by  which  R  inhibits  the  actomyosin-ATP  interaction 
cannot at the present time be designated.  It is possible that R  is a  chelator 
and inhibits through a reduction of ionic calcium (reaction 5). The possibility 
that  it  interacts  directly with  actomyosin as  indicated by  reaction  6  must 
also  be  considered.  There  is  no  evidence  available  which  would  allow  a 
distinction to be made between these two possibilities. 
A  question of considerable importance is whether this soluble supernatant 
relaxing  factor isolated  directly  from muscle is  identical  with  the  soluble 
relaxing factors obtained by incubation of granules and ATP (3, 5). Although 
not enough information is available for a  definitive answer to this question, 
it is of significance that all these preparations have certain common proper- 
ties. The soluble factor described here is similar to that of Briggs and Fuchs 
(3)  and  Parker  and  Gergely  (5)  in  its response to charcoal  treatment and 
dialysis. For example, Parker and Gergely were unable to prepare an active 
protein-free dialysate. Briggs and Fuchs were able to demonstrate the dialyz- 
ability of their preparation,  but only with considerable loss of activity. The 
data available  on thermal stability do not allow a  quantitative comparison 
of the various  preparations.  Parker  and  Gergely report  that  upon heating 
their material at  100°C there was approximately a  15 per cent loss in activity 
after  2  minutes and  a  50  per  cent  loss  after  15  minutes.  Similarly,  Nagai 
et al.  (6)  state that there was only a  slight loss of activity after 2 minutes at F.  FLICHS  AND  F.  N.  BRIOGS  Properties  of a Soluble Relaxing Faxtor  903 
100°C.  The soluble factor of Briggs and Fuchs showed a  50 per cent loss of 
activity  after  heating  for  5  minutes  at  70°C,  whereas  the  preparation  re- 
ported here lost on the average about 30 per cent of its activity after heating 
for 2 minutes at  100°C.  However, different preparations varied considerably 
in their stability.  The data do suggest, however, that these different groups 
of workers may be dealing with similar, if not identical, chemical compounds. 
It seems possible,  therefore, to tentatively conclude that the soluble relaxing 
factor in the supernatant was biosynthesized in the muscle and is a  natural 
component of muscle. 
The existence of a soluble inhibitor has been suggested previously. What is 
of particular physiological importance in the present studies is the discovery 
that  the  soluble  inhibitor  exists  in  muscle.  Heretofore  it  had  only  been 
produced by in vitro systems. Before this soluble relaxing factor can be given 
a  physiological role in  the regulation of muscle activity, however, it will be 
necessary to  show that its concentration actually varies with  the activity of 
muscle. The demonstration here, that the relaxing activity of soluble fractions 
of muscle can be readily assayed and that the relaxing activity of the soluble 
fraction  is  sufficiently stable  to  give  reliable  assays,  makes  such  a  project 
entirely feasible. 
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